Pelton G H, Lee Y, Davis M
Yale University School of Medicine, Department of Psychiatry and Abraham Ribcoff Research Facilities of The Connecticut Mental Health Center-1, New Haven 06519, USA.
Brain Res. 1997 Dec 19;778(2):381-7. doi: 10.1016/s0006-8993(97)00669-0.
In the rat, evidence now suggests a neurotransmitter function for the neuropeptides arginine vasopressin (AVP) and corticotropin releasing factor (CRF), implicating them in various autonomic, behavioral, and neuroendocrine responses to stress. Repeated AVP/CRF release in the pituitary portal circulation, due to stress, sensitizes and potentiates the release of ACTH from the anterior pituitary. Using a neuroanatomically well-defined behavior, the acoustic startle reflex in the rat, we sought to determine whether an interaction between AVP, CRF and stress might also occur centrally as measured by increased behavioral sensitivity to AVP or CRF given directly into the brain. The first experiment tested whether repeated intraventricular (i.c.v.) infusion of AVP would lead to an increase in the excitatory effect of a subthreshold dose of AVP on the acoustic startle reflex when infused 48 h later. Different groups of rats were infused with various doses of AVP (0.3, 3, or 30 ng) or vehicle on Day 1 and tested for startle over the next 60 min. On Day 2, 48 h later, all animals were infused with a single dose of AVP (300 pg) and tested for startle. Infusion of AVP on Day 1 did not increase startle consistently at any dose, but did lead to a sensitized excitatory effect of AVP on startle on Day 2 which was non-monotonically related to the dose of AVP given on Day 1. Experiment 2 tested whether AVP on Day 1 would sensitize the excitatory effects on startle of CRF given i.c.v. on Day 2. Different groups of rats were infused i.c.v. with various doses of AVP (10, 30, 100, 300 pg) or vehicle on Day 1. On Day 2, 48 h later, all rats were infused with a subthreshold dose of CRF (0.25 microg). Infusion of AVP on Day 1 led to a sensitized excitatory effect of CRF on startle on Day 2 which was non-monotonically related to the dose of AVP given on Day 1. In experiment 3, we tested whether footshocks given on Day 1 would sensitize the excitatory effect of CRF on startle tested 48 h later. Different groups were given footshocks (0.2, 0.4, 0.8, 1.6 mA) on Day 1. On Day 2, 48 h later, all rats were infused with a subthreshold dose of CRF (0.25 microg). Footshocks given on Day 1 led to a sensitized excitatory effect of CRF on startle on Day 2 which was non-monotonically related to the intensity of footshock on Day 1. Taken together, these results suggest that an interaction between AVP, CRF and stress may occur centrally, consistent with other studies showing similar interactions peripherally. This may provide a model system for analyzing how prior stress leads to enhanced behavioral reactions to subsequent stressors and a mechanism to explain dysregulation of the stress response.
在大鼠中,目前有证据表明神经肽精氨酸加压素(AVP)和促肾上腺皮质激素释放因子(CRF)具有神经递质功能,这表明它们参与了对应激的各种自主神经、行为和神经内分泌反应。由于应激导致垂体门脉循环中AVP/CRF反复释放,从而使垂体前叶促肾上腺皮质激素(ACTH)的释放敏感化并增强。利用大鼠明确的神经解剖学行为——听觉惊吓反射,我们试图确定AVP、CRF与应激之间的相互作用是否也可能在中枢发生,这可通过直接注入脑内的AVP或CRF使行为敏感性增加来衡量。第一个实验测试了反复脑室内(i.c.v.)注入AVP是否会导致在48小时后注入阈下剂量的AVP时,对听觉惊吓反射的兴奋作用增强。在第1天,给不同组的大鼠注入不同剂量的AVP(0.3、3或30 ng)或赋形剂,并在接下来的60分钟内测试惊吓反应。48小时后的第2天,给所有动物注入单剂量的AVP(300 pg)并测试惊吓反应。第1天注入AVP在任何剂量下均未持续增加惊吓反应,但确实导致第2天AVP对惊吓的兴奋作用敏感化,且与第1天给予的AVP剂量呈非单调关系。实验2测试了第1天的AVP是否会使第2天脑室内注入的CRF对惊吓的兴奋作用敏感化。在第1天,给不同组的大鼠脑室内注入不同剂量的AVP(10、30、100、300 pg)或赋形剂。48小时后的第2天,给所有大鼠注入阈下剂量的CRF(0.25μg)。第1天注入AVP导致第2天CRF对惊吓的兴奋作用敏感化,且与第1天给予的AVP剂量呈非单调关系。在实验3中,我们测试了第1天给予的足部电击是否会使48小时后测试的CRF对惊吓的兴奋作用敏感化。在第1天,给不同组给予足部电击(0.2、0.4、0.8、1.6 mA)。48小时后的第2天,给所有大鼠注入阈下剂量的CRF(0.25μg)。第1天给予的足部电击导致第2天CRF对惊吓的兴奋作用敏感化,且与第1天足部电击的强度呈非单调关系。综上所述,这些结果表明AVP、CRF与应激之间的相互作用可能在中枢发生,这与其他显示外周类似相互作用的研究一致。这可能为分析先前的应激如何导致对后续应激源的行为反应增强提供一个模型系统,并为解释应激反应失调提供一种机制。